Neuropsychiatric Manifestations of Mast Cell Activation Syndrome and Response to Mast-Cell-Directed Treatment: A Case Series
Open Access
- 31 October 2023
- journal article
- research article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 13 (11) , 1562
Abstract
Mast cell activation syndrome (MCAS) is an immune disease with an estimated prevalence of 17%. Mast cell chemical mediators lead to heterogeneous multisystemic inflammatory and allergic manifestations. This syndrome is associated with various neurologic and psychiatric disorders, including headache, dysautonomia, depression, generalized anxiety disorder, and many others. Although MCAS is common, it is rarely recognized, and thus, patients can suffer for decades. The syndrome is caused by aberrant mast cell reactivity due to the mutation of the controller gene. A case series is presented herein including eight patients with significant neuropsychiatric disorders that were often refractory to standard medical therapeutics. Five patients had depression, five had generalized anxiety disorder, and four had panic disorder. Other psychiatric disorders included attention-deficit hyperactivity disorder, obsessive compulsive disorder, phobias, and bipolar disorder. All eight patients were subsequently diagnosed with mast cell activation syndrome; six had comorbid autonomic disorders, the most common being postural orthostatic tachycardia syndrome; and four had hypermobile Ehlers-Danlos syndrome. All patients experienced significant improvements regarding neuropsychiatric and multisystemic symptoms after mast-cell-directed therapy. In neuropsychiatric patients who have systemic symptoms and syndromes, it is important to consider the presence of an underlying or comorbid MCAS.Keywords
This publication has 55 references indexed in Scilit:
- Mastocytosis in adulthood and neuropsychiatric disordersTranslational Research, 2016
- Mast cell activation disease: An underappreciated cause of neurologic and psychiatric symptoms and diseasesBrain, Behavior, and Immunity, 2015
- The genetic basis of mast cell activation disease - looking through a glass darklyCritical Reviews in Oncology/Hematology, 2015
- Mast Cells and NeuroinflammationMedical Science Monitor Basic Research, 2014
- Familial Occurrence of Systemic Mast Cell Activation DiseasePLOS ONE, 2013
- Mast cell activation contributes to sickle cell pathobiology and pain in miceBlood, 2013
- Investigation into mechanisms mediating the inhibitory effect of 1,4-benzodiazepines on mast cells by gene expression profilingLife Sciences, 2013
- Depression in Patients with Mastocytosis: Prevalence, Features and Effects of Masitinib TherapyPLOS ONE, 2011
- Histamine Pharmacology and New CNS Drug TargetsCNS Neuroscience & Therapeutics, 2010
- Multiple novel alterations inKittyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorderScandinavian Journal of Gastroenterology, 2007